Table 4.
Total FAs in the blood of hyperlipidemic patients and normolipidemic controls following stratification according to PNPLA3 I148M and ABCB1 G2677T genotypes.
| Genotype | Group | p 1 | |
|---|---|---|---|
| PNPLA3 I148M | Normolipidemics (n) | Hyperlipidemics (n) | |
| CC (II) | 7.59 ± 2.463 (21) | 9.44 ± 3.374 (26) | 0.041 |
| CG (IM) | 8.08 ± 2.262 (15) | 8.25 ± 1.946 (27) | 0.795 |
| GG (MM) | 6.70 ± 1.421 (4) | 12.57 ± 2.541 (8) | 0.002 |
| p 2 | 0.601 | 0.006 | |
| ABCB1 G2677T | |||
| GG | 8.23 ± 2.524 (15) | 8.42 ± 2.380 (26) | 0.817 |
| GT | 7.92 ± 2.470 (16) | 9.43 ± 2.577 (22) | 0.078 |
| TT | 6.73 ± 1.044 (11) | 10.78 ± 4.044 (14) | 0.003 |
| p 2 | 0.282 | 0.056 | |
1 Student t-test; 2 ANCOVA with body mass index (BMI), HbA1c as covariates.